There is a growing global burden of liver disease with the current management for complications of liver cirrhosis being reactive as opposed to proactive, affecting outcomes. Management can often be ...
Background and Aims: Neuropathy in association with chronic liver disease, including cirrhosis, is recognized; however, there are differences in the incidence and type of neuropathy reported.
FORT LAUDERDALE, FL / ACCESSWIRE / November 22, 2024 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of ...
Category 2 - Etiology: Seronegative hepatitis, hepatitis A, hepatitis B, or an idiosyncratic drug reaction ... graft dysfunction on days 0 to 7 after liver transplantation with at least two ...
Aug. 21, 2024 — A research team has shown the benefits of camu-camu on non-alcoholic fatty liver disease. This exotic fruit reduces liver fat ... Liver Transplant Outperforms Other Therapies for ...
(NASDAQ: NASDAQ:VIR) announced today that its treatments for chronic hepatitis ... for the Study of Liver Diseases (AASLD), in San Diego, California, later today. The orphan drug designation ...
GSK has revealed updated results from its phase 2b trial of its antisense drug ... New England Journal of Medicine, bepirovirsen at a dose of 300 mg per week over 24 weeks resulted in sustained ...
It is this fibrosis that leads to cirrhosis of the liver, and anywhere between 12-20 per cent of people with type 2 diabetes ... Some newer antidiabetic drugs may help, including SGLT-2 inhibitors and ...